Difference between revisions of "Scientific Articles on Psychedelics"

From DMT-Nexus Wiki
Jump to: navigation, search
(→‎Salvia Divinorum)
(→‎Other)
Line 264: Line 264:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen]]
 
|
 
|
 
|0px
 
|0px
Line 270: Line 270:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:entheogens and education potential.pdf|Entheogens and education potential]]
 
|
 
|
 
|0px
 
|0px
Line 276: Line 276:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:hallucinogens and redemption.pdf|Hallucinogens and redemption]]
 
|
 
|
 
|0px
 
|0px
Line 282: Line 282:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:HPPD - flashbacks.pdf|HPPD - flashbacks]]
 
|
 
|
 
|0px
 
|0px
Line 288: Line 288:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872]]
 
|
 
|
 
|0px
 
|0px
Line 294: Line 294:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC]]
 
|
 
|
 
|0px
 
|0px
 
}}
 
}}
−
 
−
[{UP}PDF/Science/bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen.pdf]
 
−
[{UP}PDF/Science/entheogens and education potential.pdf|Entheogens and education potential.pdf]
 
−
[{UP}PDF/Science/hallucinogens and redemption.pdf|Hallucinogens and redemption.pdf]
 
−
[{UP}PDF/Science/HPPD - flashbacks.pdf|HPPD - flashbacks.pdf]
 
−
[{UP}PDF/Science/JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872.pdf]
 
−
[{UP}PDF/Science/Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC.pdf]
 
−
 
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA]]
 
|
 
|
 
|0px
 
|0px
Line 314: Line 306:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Nichols - Hallucinogens.pdf|Nichols - Hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 320: Line 312:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology]]
 
|
 
|
 
|0px
 
|0px
Line 326: Line 318:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology]]
 
|
 
|
 
|0px
 
|0px
Line 332: Line 324:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep]]
 
|
 
|
 
|0px
 
|0px
Line 338: Line 330:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psychedelic adverse effects.pdf|Psychedelic adverse effects]]
 
|
 
|
 
|0px
 
|0px
 
}}
 
}}
−
 
−
 
−
 
−
[{UP}PDF/Science/natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA.pdf]
 
−
[{UP}PDF/Science/Nichols - Hallucinogens.pdf|Nichols - Hallucinogens.pdf]
 
−
[{UP}PDF/Science/pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology.pdf]
 
−
[{UP}PDF/Science/pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology.pdf]
 
−
[{UP}PDF/Science/Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep.pdf]
 
−
[{UP}PDF/Science/psychedelic adverse effects.pdf|Psychedelic adverse effects.pdf]
 
−
 
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach]]
 
|
 
|
 
|0px
 
|0px
Line 360: Line 342:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 366: Line 348:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model]]
 
|
 
|
 
|0px
 
|0px
Line 372: Line 354:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting]]
 
|
 
|
 
|0px
 
|0px
Line 378: Line 360:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:serotonin and hallucinogens.pdf|Serotonin and hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 384: Line 366:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:study of Values of psychedelic users.pdf|Study of Values of psychedelic users]]
 
|
 
|
 
}}
 
}}
−
 
−
[{UP}PDF/Science/Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach.pdf]
 
−
[{UP}PDF/Science/Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens.pdf]
 
−
[{UP}PDF/Science/psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model.pdf]
 
−
[{UP}PDF/Science/reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting.pdf]
 
−
[{UP}PDF/Science/serotonin and hallucinogens.pdf|Serotonin and hallucinogens.pdf]
 
−
[{UP}PDF/Science/study of Values of psychedelic users.pdf|Study of Values of psychedelic users.pdf]
 
  
 
[[Category:Supplementary Reference]]
 
[[Category:Supplementary Reference]]

Revision as of 23:41, 16 February 2009

Error.png Note: This page is a work in progress -- its content throughout is not yet complete.


Ayahuasca

Page white acrobat.png Ayahuasca and SSRI Interactions Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369.
Page white acrobat.png Ayahuasca Adolescents ritual use Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144.
Page white acrobat.png ayahuasca first time psychological after effects Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30.
Page white acrobat.png Ayahuasca and human destiny McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234.
Page white acrobat.png Another Ayahuasca EEG study Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628.
Page white acrobat.png Ayahuasca in adolescence psychiatric evaluation
Page white acrobat.png ayahuasca in cross cultural perspective
Page white acrobat.png Ayahuasca neuroimaging
Page white acrobat.png Bringing Ayahuasca to clinical laboratory
Page white acrobat.png Effects of ayahuasca on panic and anxiety.pdf
Page white acrobat.png Globalization of ayahuasca
Page white acrobat.png Human pharmacology of ayahuasca
Page white acrobat.png Pharmacokinetics of hoasca in healthy humans
Page white acrobat.png Risk assessment of ritual ayahuasca use
Page white acrobat.png Thesis - Ayahuascapharmacology part1
Page white acrobat.png Thesis - ayahuascapharmacology part2
Page white acrobat.png Various alkaloid profiles in aya decoction

DMT

Page white acrobat.png DMT and BCarbolines in human plasma after dose
Page white acrobat.png DMT endogenous anxiolytic role
Page white acrobat.png DMT in psychiatric patients
Page white acrobat.png DMT psychopharmacology
Page white acrobat.png Excretion of DMT in Psychiatric Patients

Ibogaine

Page white acrobat.png Fatalities after ibogaine use
Page white acrobat.png Ibogaine and cocaine abuse
Page white acrobat.png Ibogaine and facilitation of memory retrieval
Page white acrobat.png Ibogaine mechanisms of anti addiction
Page white acrobat.png Ibogaine safety and efficacy

LSD

Page white acrobat.png Long term effects of LSD
Page white acrobat.png Therapy with LSD

Peyote

Page white acrobat.png A Study on mescaline in human subjects
Page white acrobat.png Peyote long term psychological cognitive effects
Page white acrobat.png Prehistoric peyote use

Psilocybin

Page white acrobat.png Cluster headache lsd psilocybin
Page white acrobat.png Effects of psilocybin on humans
Page white acrobat.png Effects of psilocybin on perception of time
Page white acrobat.png Psilocybin and mystical experiences
Page white acrobat.png Psilocybin and OCD
Page white acrobat.png Psilocybin investigator brochure
Page white acrobat.png Psilocybin, attention and working memory
Page white acrobat.png Psychedelic mushrooms in buddhist tradition

Salvia Divinorum

Page white acrobat.png Salvia divinorum pattern of use
Page white acrobat.png Salv_A_PNAS

Other

Page white acrobat.png Bufo alvarius - a potent hallucinogen
Page white acrobat.png Entheogens and education potential
Page white acrobat.png Hallucinogens and redemption
Page white acrobat.png HPPD - flashbacks
Page white acrobat.png JPharmBioAn-41-3-872
Page white acrobat.png Mining_Recepterome_Review_JBC
Page white acrobat.png Natural hallucinogens growing in USA
Page white acrobat.png Nichols - Hallucinogens
Page white acrobat.png Pharmañopo - Yopo pharmacology
Page white acrobat.png Pharmepena - epena pharmacology
Page white acrobat.png Proposed Mechanism for Dreams and Sleep
Page white acrobat.png Psychedelic adverse effects
Page white acrobat.png Psychointegrators multidisciplinary approach
Page white acrobat.png Psychopharmacology of hallucinogens
Page white acrobat.png Psychosis and hallucinogens consciousness model
Page white acrobat.png Reducing drug problems with set and setting
Page white acrobat.png Serotonin and hallucinogens
Page white acrobat.png Study of Values of psychedelic users
Retrieved from "https://wiki.dmt-nexus.me/w/index.php?title=Scientific_Articles_on_Psychedelics&oldid=477"